Tag: FDA Adverse Event Reporting System
Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
The FDA doesn't stop monitoring generic drugs after approval. Using systems like FAERS, Sentinel, and MedWatch, it tracks real-world safety issues, investigates manufacturing changes, and uses AI to catch hidden risks. Here's how it works.